252 related articles for article (PubMed ID: 31424020)
1. Combination antifungals as an effective means of salvage in paediatric leukaemia patients with invasive fungal infections.
Meena JP; Gupta AK; Jana M; Seth R
Indian J Med Microbiol; 2019; 37(1):109-112. PubMed ID: 31424020
[TBL] [Abstract][Full Text] [Related]
2. Combination antifungal treatment for invasive fungal disease after hematopoietic stem cell transplantation in children with hematological disorders.
Qiu KY; Liao XY; Fang JP; Xu HG; Li Y; Huang K; Zhou DH
Transpl Infect Dis; 2019 Jun; 21(3):e13066. PubMed ID: 30859662
[TBL] [Abstract][Full Text] [Related]
3. Secondary antifungal prophylaxis in allogeneic hematopoietic stem cell transplant recipients with invasive fungal infection.
Pepeler MS; Yildiz Ş; Yegin ZA; Özkurt ZN; Tunçcan ÖG; Erbaş G; Köktürk N; Kalkanci A; Yildirim Z
J Infect Dev Ctries; 2018 Sep; 12(9):799-805. PubMed ID: 31999640
[TBL] [Abstract][Full Text] [Related]
4. A rescue therapy with a combination of caspofungin and liposomal amphotericin B or voriconazole in children with haematological malignancy and refractory invasive fungal infections.
Yilmaz D; Balkan C; Ay Y; Akin M; Karapinar B; Kavakli K
Mycoses; 2011 May; 54(3):234-42. PubMed ID: 19906090
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of Invasive Fungal Infection in Childhood Acute Lymphoblastic Leukemia with Amphotericin B and Voriconazole].
Yi XL; Mao Q; Jiang Y; Guo XB; Chen Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Dec; 25(6):1627-1630. PubMed ID: 29262887
[TBL] [Abstract][Full Text] [Related]
6. Antifungal combination therapy for invasive fungal infections in a paediatric oncology and haematology department: A retrospective analysis of practice.
Lignieres G; Guitard J; Alby-Laurent F; Rambaud J; Bigot J; Morand K; Leverger G; Tabone MD
J Mycol Med; 2022 Aug; 32(3):101276. PubMed ID: 35405593
[TBL] [Abstract][Full Text] [Related]
7. Azole-based chemoprophylaxis of invasive fungal infections in paediatric patients with acute leukaemia: an internal audit.
Yunus S; Pieper S; Kolve H; Goletz G; Jürgens H; Groll AH
J Antimicrob Chemother; 2014 Mar; 69(3):815-20. PubMed ID: 24198097
[TBL] [Abstract][Full Text] [Related]
8. Compare the efficacy of antifungal agents as primary therapy for invasive aspergillosis: a network meta-analysis.
Liu A; Xiong L; Wang L; Zhuang H; Gan X; Zou M; Wang X
BMC Infect Dis; 2024 Jun; 24(1):581. PubMed ID: 38867163
[TBL] [Abstract][Full Text] [Related]
9. Cost-Effectiveness of Antifungal Supplementation of Corneal Cold Storage Media.
Gibbons A; Leung EH; Yoo SH
Ophthalmology; 2020 May; 127(5):582-588. PubMed ID: 31892423
[TBL] [Abstract][Full Text] [Related]
10. First case of proven invasive pulmonary infection due to Trichoderma longibrachiatum in a neutropenic patient with acute leukemia.
Sautour M; Chrétien ML; Valot S; Lafon I; Basmaciyan L; Legouge C; Verrier T; Gonssaud B; Abou-Hanna H; Dalle F; Caillot D
J Mycol Med; 2018 Dec; 28(4):659-662. PubMed ID: 30477694
[TBL] [Abstract][Full Text] [Related]
11. Role of Antifungal Susceptibility Testing in Non-Aspergillus Invasive Mold Infections.
Lamoth F; Damonti L; Alexander BD
J Clin Microbiol; 2016 Jun; 54(6):1638-1640. PubMed ID: 27008871
[TBL] [Abstract][Full Text] [Related]
12. Voriconazole plus terbinafine combination antifungal therapy for invasive Lomentospora prolificans infections: analysis of 41 patients from the FungiScope® registry 2008-2019.
Jenks JD; Seidel D; Cornely OA; Chen S; van Hal S; Kauffman C; Miceli MH; Heinemann M; Christner M; Jover Sáenz A; Burchardt A; Kemmerling B; Herbrecht R; Steinmann J; Shoham S; Gräber S; Pagano L; Deeren D; Aslam S; Taplitz R; Revankar SG; Baddley J; Mehta SR; Reed S; Slavin MA; Hoenigl M
Clin Microbiol Infect; 2020 Jun; 26(6):784.e1-784.e5. PubMed ID: 31972317
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of invasive fungal infections with voriconazole. Evaluation of experience with compassionate use of voriconazole in Spain].
Díaz Pedroche C; Cisneros JM; Lumbreras C; Aguado JM;
Rev Esp Quimioter; 2005 Jun; 18(2):149-58. PubMed ID: 16130037
[TBL] [Abstract][Full Text] [Related]
14. Clinical experience of the use of voriconazole, caspofungin or the combination in primary and salvage therapy of invasive aspergillosis in haematological malignancies.
Raad II; Zakhem AE; Helou GE; Jiang Y; Kontoyiannis DP; Hachem R
Int J Antimicrob Agents; 2015 Mar; 45(3):283-8. PubMed ID: 25455847
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic administration of voriconazole with two different doses for invasive fungal infection in children and adolescents with acute myeloid leukemia.
Sano H; Kobayashi R; Hori D; Kishimoto K; Suzuki D; Yasuda K; Kobayashi K
J Microbiol Immunol Infect; 2018 Apr; 51(2):260-266. PubMed ID: 27329132
[TBL] [Abstract][Full Text] [Related]
16. Invasive infections due to Saprochaete and Geotrichum species: Report of 23 cases from the FungiScope Registry.
Durán Graeff L; Seidel D; Vehreschild MJ; Hamprecht A; Kindo A; Racil Z; Demeter J; De Hoog S; Aurbach U; Ziegler M; Wisplinghoff H; Cornely OA;
Mycoses; 2017 Apr; 60(4):273-279. PubMed ID: 28150341
[TBL] [Abstract][Full Text] [Related]
17. New pharmacological opportunities for the treatment of invasive mould diseases.
Ledoux MP; Toussaint E; Denis J; Herbrecht R
J Antimicrob Chemother; 2017 Mar; 72(suppl_1):i48-i58. PubMed ID: 28355467
[TBL] [Abstract][Full Text] [Related]
18. Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin.
Aliff TB; Maslak PG; Jurcic JG; Heaney ML; Cathcart KN; Sepkowitz KA; Weiss MA
Cancer; 2003 Feb; 97(4):1025-32. PubMed ID: 12569602
[TBL] [Abstract][Full Text] [Related]
19. Antifungal Lock Therapy with Liposomal Amphotericin B: A Prospective Trial.
McGhee W; Michaels MG; Martin JM; Mazariegos GV; Green M
J Pediatric Infect Dis Soc; 2016 Mar; 5(1):80-4. PubMed ID: 26908494
[TBL] [Abstract][Full Text] [Related]
20. Multicentre surveillance study on feasibility, safety and efficacy of antifungal combination therapy for proven or probable invasive fungal diseases in haematological patients: the SEIFEM real-life combo study.
Candoni A; Caira M; Cesaro S; Busca A; Giacchino M; Fanci R; Delia M; Nosari A; Bonini A; Cattaneo C; Melillo L; Caramatti C; Milone G; Scime' R; Picardi M; Fanin R; Pagano L;
Mycoses; 2014 Jun; 57(6):342-50. PubMed ID: 24373120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
